Clinical, biological, and prognostic implications of SF3B1 co-occurrence mutations in very low/low- and intermediate-risk MDS patients

1. Janusz, K.
2. Izquierdo, M.M.
3. Cadenas, F.L.
4. Ramos, F.
5. Sánchez, J.M.H.
6. Lumbreras, E.
7. Robledo, C.
8. del Real, J.S.
9. Caballero, J.C.
10. Collado, R.
11. Bernal, T.
12. Pedro, C.
13. Insunza, A.
14. de Paz, R.
15. Xicoy, B.
16. Salido, E.
17. García, J.S.
18. Mínguez, S.S.
19. García, C.M.
20. Muñoz, A.M.S.
21. Barba, M.S.
22. Rivas, J.M.H.
23. Abáigar, M.
24. Campelo, M.D.